Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of Shengbai oral liquid for chemotherapy-related cancer fatigue
ChiCTR2200060539Phase 4Not yet recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jun 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Shengbai oral liquid in cancer-related fatigue (CRF) (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Total Piper Fatigue Scale score. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
Shengbai oral liquid
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on ChiCTR2200060539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060539.